Q
Qianjin Liao
Researcher at Central South University
Publications - 153
Citations - 6685
Qianjin Liao is an academic researcher from Central South University. The author has contributed to research in topics: Nasopharyngeal carcinoma & Medicine. The author has an hindex of 38, co-authored 113 publications receiving 4225 citations. Previous affiliations of Qianjin Liao include Chinese Ministry of Education & Chongqing University.
Papers
More filters
Journal ArticleDOI
Circular RNAs in human cancer
Yumin Wang,Yongzhen Mo,Zhaojian Gong,Xiang Yang,Mo Yang,Shanshan Zhang,Fang Xiong,Bo Xiang,Ming Zhou,Qianjin Liao,Wenling Zhang,Xiayu Li,Xiaoling Li,Yong Li,Yong Li,Guiyuan Li,Zhaoyang Zeng,Wei Xiong +17 more
TL;DR: The role of circRNAs as molecular markers or potential targets will provide promising application perspectives, such as early tumor diagnosis, therapeutic evaluation, prognosis prediction, and even gene therapy for tumors.
Journal ArticleDOI
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
Rongfang He,Rongfang He,Rongfang He,Peng Liu,Xiaoming Xie,Yujuan Zhou,Qianjin Liao,Wei Xiong,Wei Xiong,Xiaoling Li,Xiaoling Li,Guiyuan Li,Guiyuan Li,Zhaoyang Zeng,Zhaoyang Zeng,Hailin Tang +15 more
TL;DR: It is concluded that circGFRA1 may function as a competing endogenous RNA (ceRNA) to regulate GFRA1 expression through sponging miR-34a to exert regulatory functions in TNBC.
Journal ArticleDOI
Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
Min Su,Yuhang Xiao,Junliang Ma,Yanyan Tang,Bo Tian,Yuqin Zhang,Xu Li,Zhining Wu,Desong Yang,Yong Zhou,Hui Wang,Qianjin Liao,Wenxiang Wang +12 more
TL;DR: Current knowledge regarding the functions ofcircRNAs in the hallmarks, stemness, resistance of cancer, as well as the possibility of circRNAs as biomarkers in cancer are summarized.
Journal ArticleDOI
Role of the NFκB-signaling pathway in cancer
Longzheng Xia,Shiming Tan,Yujuan Zhou,Jingguan Lin,Heran Wang,Linda Oyang,Yutong Tian,Lu Liu,Min Su,Hui Wang,Deliang Cao,Qianjin Liao +11 more
TL;DR: Current understanding of the NFκB-signaling pathway in cancer is updated and targeted therapies against effectors in oncogenic signaling have improved the outcomes of cancer patients.
Journal ArticleDOI
The cancer metabolic reprogramming and immune response.
Longzheng Xia,Linda Oyang,Jinguan Lin,Shiming Tan,Yaqian Han,Nayiyuan Wu,Pin Yi,Pin Yi,Lu Tang,Lu Tang,Qing Pan,Qing Pan,Shan Rao,Jiaxin Liang,Yanyan Tang,Min Su,Xia Luo,Yiqing Yang,Yingrui Shi,Hui Wang,Yujuan Zhou,Qianjin Liao +21 more
TL;DR: The overlapping metabolic reprogramming of cancer and immune cells is a putative determinant of the antitumor immune response in cancer Increased evidence suggests that cancer metabolism not only plays a crucial role in cancer signaling for sustaining tumorigenesis and survival, but also has wider implications in the regulation of the immune response through both the release of metabolites and affecting the expression of immune molecules, such as lactate, PGE2, arginine, etc.